Also known as: Aclacinomycin A

Therapeutic indications

Aclarubicin is indicated for:

Acute leukemias

at least one of
Acute lymphoblastic leukaemia

Acute myeloid leukaemia

Acute promyelocytic leukaemia

Acute monocytic leukaemia

Acute megakaryoblastic leukaemia

Acute leukaemia of unspecified cell type

For this indication, competent medicine agencies globally authorize below treatments (click for details):


Aclarubicin is contraindicated in the following cases:

Pre-existing heart disorder

at least one of
Chronic rheumatic heart diseases

Ischaemic heart diseases

Other forms of heart disease

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner